Bertel Noemi, Witassek Fabienne, Puhan Milo, Erne Paul, Rickli Hans, Naegeli Barbara, Pedrazzini Giovanni, Stauffer Jean-Christophe, Radovanovic Dragana
University of Zurich, AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, 8001 Zurich, Switzerland.
University of Zurich, Epidemiology, Biostatistics and Prevention Institute, 8001 Zurich, Switzerland.
Int J Cardiol. 2017 Mar 1;230:604-609. doi: 10.1016/j.ijcard.2016.12.047. Epub 2016 Dec 20.
Diagnosis of acute myocardial infarction (MI) is challenging in pacemaker patients. Little is known about this patient group.
Patients with MI enrolled in the Swiss national AMIS Plus registry between January 2005 and December 2015 were analyzed. All patients with either paced ventricular rhythm or sinus rhythm with intrinsic ventricular conduction (IVC) were included in this study. Outcomes using crude data and propensity score matching were compared between patients with pacemaker rhythm and patients with IVC. The primary endpoint was in-hospital death.
Data from 300 patients with paced rhythm and 27,595 with IVC were analyzed. Patients with pacemaker rhythm were older (78.2y vs 65.4y; p<0.001), had more comorbidities (Charlson Index (CCI)>1: 54.0% vs 21.1%; p<0.001) and a higher rate of heart failure upon presentation (Killip class>2, 11.0% vs 5.9%; p<0.001) compared to patients with IVC. Door to balloon time in patients undergoing acute PCI is markedly delayed in contrast to patients with IVC (280min vs 85min; p<0.001). Consequently, crude mortality in patients with pacemakers was high (11.3% vs 4.6%; p<0.001). However, when analyzed with propensity matching for gender, age, CCI>1 and Killip>2, mortality was similar (11.2% vs 10.5%; p=0.70).
Pacemaker patients with acute MI represent a high-risk group with doubled crude mortality compared to patients without pacemakers, due to higher age and higher Killip class. Diagnosis is difficult and results in delayed treatment. Treatment algorithms for MI with paced rhythm should possibly be adapted to those used for STEMI or new left bundle branch block.
NCT01305785.
急性心肌梗死(MI)在起搏器植入患者中的诊断具有挑战性。目前对这一患者群体了解甚少。
分析2005年1月至2015年12月期间纳入瑞士国家AMIS Plus注册研究的心肌梗死患者。本研究纳入所有心室起搏心律或伴有室内传导(IVC)的窦性心律患者。比较起搏器心律患者和IVC患者使用原始数据和倾向评分匹配的结局。主要终点是院内死亡。
分析了300例起搏器心律患者和27595例IVC患者的数据。与IVC患者相比,起搏器心律患者年龄更大(78.2岁对65.4岁;p<0.001),合并症更多(Charlson指数(CCI)>1:54.0%对21.1%;p<0.001),就诊时心力衰竭发生率更高(Killip分级>2,11.0%对5.9%;p<0.001)。与IVC患者相比,接受急性PCI治疗的患者门球时间明显延迟(280分钟对85分钟;p<0.001)。因此,起搏器患者的粗死亡率较高(11.3%对4.6%;p<0.001)。然而,在按性别、年龄、CCI>1和Killip>2进行倾向匹配分析时,死亡率相似(11.2%对10.5%;p=0.70)。
急性心肌梗死的起搏器患者是高危人群,由于年龄较大和Killip分级较高,其粗死亡率是无起搏器患者的两倍。诊断困难且导致治疗延迟。有起搏心律的心肌梗死治疗算法可能应适用于ST段抬高型心肌梗死或新出现的左束支传导阻滞所采用的算法。
NCT01305785。